CBU
NGVT icon

CIBC Bancorp USA’s Ingevity NGVT Stock Holding History

CIBC Bancorp USA’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$215K Buy
+3,889
New +$202K ﹤0.01% 1226

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

CIBC Bancorp USA's NGVT Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in Ingevity (NGVT) in Q3 2025: 3,889 shares worth $215K. The stake represents ﹤0.01% of the portfolio and ranks #1226 among its holdings.

298 funds tracked by Wall St. Rank hold NGVT as of Q3 2025.

  • CIBC Bancorp USA held 3,889 shares of Ingevity worth $215K as of Q3 2025.
  • Ingevity was a new CIBC Bancorp USA position in Q3 2025.
  • Ingevity made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1226 holding.
  • 298 funds tracked by Wall St. Rank held Ingevity as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.